Skip to main content
Top

Clinical and Translational Oncology

Issue 9/2014

Content (12 Articles)

Open Access Educational Series - Blue Series

Overview of a chemoresponse assay in ovarian cancer

E. C. Grendys Jr., J. V. Fiorica, J. W. Orr Jr., R. Holloway, D. Wang, C. Tian, J. K. Chan, T. J. Herzog

Educational Series–Red Series

Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review

G. Treglia, R. Sadeghi, A. Del Sole, L. Giovanella

Research Article

Expression of Wilms’ tumor gene (WT1) is associated with survival in malignant pleural mesothelioma

S. Cedrés, M. A. Montero, E. Zamora, A. Martínez, P. Martínez, L. Fariñas, A. Navarro, D. Torrejon, A. Gabaldon, S. Ramon y Cajal, E. Felip

Research Article

Snail1 correlates with patient outcomes in E-cadherin-preserved gastroesophageal junction adenocarcinoma

H. Dong, L. Xie, C. Tang, S. Chen, Q. Liu, Q. Zhang, W. Zheng, Z. Zheng, H. Zhang

Research Article

Cell origins and significance of IL-17 in malignant pleural effusion

Y. Gong, S. X. Chen, B. A. Gao, R. C. Yao, L. Guan

Open Access Research Article

Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer

J. A. Pérez-Fidalgo, B. Bermejo, I. Chirivella, M. T. Martínez, I. González, J. M. Cejalvo, I. Catoira, P. Martínez, E. Contel, A. Lluch

Research Article

Iron deficiency in patients with solid tumours: prevalence and management in clinical practice

J. de Castro, P. Gascón, A. Casas, J. Muñoz-Langa, V. Alberola, M. Cucala, F. Barón

Research Article

Exclusive radiotherapy for gliomatosis cerebri: long-term follow-up at a single institution

K. Kim, E. K. Chie, H. J. Park, D. G. Kim, H.-W. Jung, S.-H. Park, I. H. Kim

Research Article

Intraoperative radiotherapy-containing multidisciplinary management of trunk-wall soft-tissue sarcomas

C. V. Sole, F. A. Calvo, M. Cambeiro, A. Polo, A. Montero, R. Hernanz, C. Gonzalez, M. Cuervo, D. Perez, M. S. Julian, R. Martinez-Monge

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine